Discontinued Operations - Sale of Hemostasis Business (Details) - USD ($) $ in Thousands		3 Months Ended		12 Months Ended
	Feb. 01, 2016	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of businesses				$ 437,875	$ 0	$ 0
Contingent purchase price from sale of businesses		$ 0		143,700	0
Operating expenses:
Impairment				0	133,273	0
Gain from sale of business				288,301	0	0
Income (loss) from discontinued operations, net of tax				184	(130,826)	(32,529)
Amounts reclassified from accumulated other comprehensive income				9,665
Hemostasis Business [Member] | Discontinued operations, disposed of by sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of businesses	$ 174,100			174,068	0	0
Contingent purchase price from sale of businesses	235,000			78,000
Goodwill impairment charge		24,500			24,500
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net product revenues				1,275	65,754	64,718
Operating expenses:
Cost of product revenue				1,424	75,889	54,300
Research and development				90	7,568	19,669
Selling, general and administrative				542	560	27,210
Impairment		133,300		0	133,266	0
Total operating expenses				2,056	217,283	101,179
Income (loss) from operations				(781)	(151,529)	(36,461)
Gain from sale of business				1,004	0	0
Other expense, net				(39)	(745)	(596)
Income (loss) from discontinued operations before income taxes				184	(152,274)	(37,057)
Benefit for income taxes				0	(21,448)	(4,528)
Income (loss) from discontinued operations, net of tax				184	(130,826)	(32,529)
Assets:
Inventory		53,765			53,765
Prepaid expenses and other current assets		1,153			1,153
Fixed assets, net		1,913			1,913
Intangibles, net		374,779			374,779
Allowance for reduction of assets of business held for sale		(108,773)			(108,773)
Total assets sold/held for sale		322,837			322,837
Liabilities:
Contingent purchase price – current		28,600			28,600
Deferred tax liability		38,915			38,915
Total liabilities held for sale		$ 67,515			67,515
Discontinued Operation, Additional Disclosures [Abstract]
Depreciation from discontinued operations				0	371	142
Amortization from discontinued operations				0	42,278	20,293
Gain on sale of business				(1,004)	0	0
Asset impairment charges				0	25,800	0
Reserve for excess or obsolete inventory				0	876	0
Change in contingent consideration obligation				0	8,743	7,400
Capital expenditures				0	$ 738	$ 1,178
Foreign currency translation adjustment [Member]
Operating expenses:
Amounts reclassified from accumulated other comprehensive income				9,616
Foreign currency translation adjustment [Member] | Hemostasis Business [Member] | Discontinued operations, disposed of by sale [Member]
Operating expenses:
Amounts reclassified from accumulated other comprehensive income	$ 9,600
Asset impairment charges [Member] | Foreign currency translation adjustment [Member]
Operating expenses:
Amounts reclassified from accumulated other comprehensive income				8,400
Gain from sale of business [Member] | Foreign currency translation adjustment [Member]
Operating expenses:
Amounts reclassified from accumulated other comprehensive income				$ 1,200
Cost of product revenue [Member]
Operating expenses:
Impairment charge			$ 25,800